IL22 and ulcerative colitis: It acts as a pro-inflammatory cytokine suppressing mucin production by inhibiting goblet cells’ maturation, as occurs in ulcerative colitis patients; in contrast, IL-18 downregulates IL-22 binding protein, thereby inhibiting the capability of IL-22 to induce intestinal tissue repair and expression of antimicrobial proteins [29].